CellCentric raises $120M in Series C funding, led by RA Capital Management and Forbion. The funds will advance Inobrodib, a new treatment for cancer and multiple myeloma.
Amount Raised
$120 Million
Round Type
Series C
CambridgeManufacturingBiotechnologyHealth CareInvestors
Description
CellCentric, a Cambridge-based clinical-stage biotechnology company, raised $120M in Series C funding. The round was led by RA Capital Management, with participation from Forbion and others. The funds will be used to advance Inobrodib, a treatment targeting cancer drivers. This oral capsule drug may help those unable to access other treatments.
Quick answer
CellCentric raised $120 Million in a Series C round, dated May 19, 2025. Investors: Avego Bioscience Capital, Forbion, BrightEdge, RA Capital Management and American Cancer Society. CellCentric is based in Cambridge, England, United Kingdom.
- How much did CellCentric raise?
- CellCentric raised $120 Million in a Series C round on May 19, 2025.
- Who invested in CellCentric?
- Avego Bioscience Capital, Forbion, BrightEdge, RA Capital Management and American Cancer Society are named as investors in this round.
- What does CellCentric do?
- CellCentric is a clinical-stage biotechnology company advancing Inobrodib, a new treatment for cancer, particularly multiple myeloma.
- Where is CellCentric based and how big is it?
- CellCentric is based in Cambridge, England, United Kingdom. Fundz records about 52 employees.
- Who are the decision-makers at CellCentric?
- Fundz holds 1 contact at CellCentric. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Manufacturing and Biotechnology around the same time
Companies in the same sectors as CellCentric that raised within 45 days of this round, from Fundz verified event records.
- Loopworm raised $3.3M (Pre-Series A) on July 2, 2025.
- USpharma Ltd raised an undisclosed amount (Private Equity) on June 30, 2025.
- Helus Pharma raised $50M on June 30, 2025.
- NewcelX raised $1M (Seed) on June 27, 2025.
- Endovia Health Sciences, Inc. raised $33M on June 25, 2025.
- EMVision raised $5M (Grant) on June 16, 2025.
Who to call at CellCentric, and when
A new round usually means CellCentric is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day CellCentric raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CellCentric, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CellCentric. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CellCentric raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
CellCentric raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.